Secondary cost analysis of the REDOX trial (241 patients with severe hypoxaemia): total 12-month healthcare costs did not differ significantly between long-term oxygen 24 vs 15 h/day (-$4951; 95% CI -$10,667 to $443).
Secondary analysisn = 241
Ssegonja et al. Economic evaluation of long-term oxygen therapy: 24 hours versus 15 hours per day in severe hypoxemia-the REDOX trial